Clinical Trial Update: Sitagliptin in Prevention of Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sitagliptin for the prevention of Type 2 diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals | Conditions: Type 2 Diabetes | Phase 3 | Status: WITHDRAWN